To investigate the effect of glycyrrhizinate and phospholipids (DGPL) complex on inflammatory gene expression in cell inflammation model induced by palmitic acid (PA). Huh7 cells were divided into control, PA and PA+DGPL groups. For control group, cells were treated with BSA; for PA group, cells were incubated with 0.2 mmol/L saturated fatty acid PA, PA+DGPL group was given 20 μmol/L or 100 μmol/L DGPL in addition to 0.2 μmol/L PA. After 24 h, the expression of inflammation-related genes COX-2 and iNOS and endoplasmic reticulum (ER) stress-related gene GRP78 was determined by RT PCR. Oil red staining was conducted to observe the effect of DGLP on steatosis. Compared with control group, the expression of COX-2, iNOS and GRP78 in PA group was enhanced to 6.07±0.73(<0.05), 3.18±0.91 (<0.01) and 3.21±1.00(<0.05), respectively. Compared to control group, the expression of COX-2,iNOS and GRP78 in 100 μmol/L DGPL group was reduced to 2.40±0.76, 1.60±0.49 and 1.17 ±0.42 (<0.05); and 20 μmol DGPL had similar inhibition effect on COX-2 and iNOS elevation induced by PA (<0.01, <0.05 respectively). In addition, DGLP enhances the steatosis of Huh7 cells as demonstrated by oil red staining. PA can induce the up-regulated expression of inflammation associated genes COX-2, iNOS and ER stress-associated gene GRP78 in Huh7 cells. DGPL is able to protect Huh7 cells from PA induced inflammatory gene expression and the beneficial effect may be partially due to its unsaturated phospholipid component, which may improve ER stress and enhance steatosis.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10397053 | PMC |
http://dx.doi.org/10.3785/j.issn.1008-9292.2017.04.12 | DOI Listing |
J Biomol Struct Dyn
November 2024
Institute of Research, Development, and Innovation in Healthcare Biotechnology (IDiBE), Universidad 'Miguel Hernández', Elche-Alicante, Spain.
Glycyrrhizic acid (GLA) is the most important bioactive constituent of licorize root and exhibits antiviral, antimicrobial, anti-oxidant, anti-inflammatory, anti-allergic, and antitumor activities. GLA has an amphiphilic nature consisting of two hydrophilic and one hydrophobic part, and its mechanism of action could be mediated by its incorporation into the membrane. Furthermore, GLA presents two different forms, protonated (GLA) and deprotonated (GLAD), and has been suggested that their location inside the membrane could be different.
View Article and Find Full Text PDFPhytomedicine
December 2024
Department of Integrated Traditional Chinese and Western Medicine, Anhui University of Chinese Medicine, Hefei, Anhui, 230012, China; Research Institute of Integrated Traditional Chinese and Western Medicine, Anhui Academy of Chinese Medicine, Hefei, Anhui, 230012, China; Anhui Provincial Key Laboratory of Chinese Medicinal Formula, Hefei, Anhui, 230012, China. Electronic address:
J Sep Sci
September 2024
School of Food and Drug, Shenzhen Polytechnic University, Shenzhen, P. R. China.
Shaoyao Gancao Decoction (SGD), a traditional Chinese medicine, has been proven to have a good liver protection effect, but the mechanism and pharmacodynamic substances of SGD in the treatment of acute liver injury are still unclear. In this study, an ultra-high-performance liquid chromatography-quadrupole-time-of-flight mass spectrometry (UHPLC-Q-TOF-MS) method was established to characterize 107 chemical components of SGD and 12 compounds absorbed in rat plasma samples after oral administration of SGD. Network pharmacology was applied to construct a component-target-pathway network to screen the possible effective components of SGD in acute liver injury.
View Article and Find Full Text PDFScand J Gastroenterol
June 2024
Zhejiang University School of Medicine, Hangzhou, Zhejiang Province, China.
Background: Hepatocellular carcinoma (HCC) is the most malignant cancer worldwide. Sorafenib (SRF) is a common therapeutic drug used for patients with advanced HCC. Nevertheless, drug resistance frequently occurs in patients treated with sorafenib.
View Article and Find Full Text PDFRecent Pat Anticancer Drug Discov
January 2024
Department of Traditional Medicine, Hangzhou Children's Hospital, Hangzhou, Zhejiang, 310014, China.
Background: Multidrug resistance (MDR) of cancer cells is a major obstacle to efficient cancer chemotherapy. Combination therapy is expected to enhance the anticancer effect and reverse MDR. Numerous patents involve different kinds of nanoparticles for the co-delivery of multiple chemotherapeutics, but the FDA has approved none.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!